First-In-Human Study of [64Cu]Cu-DOTATATE PET/CT in Infective Endocarditis: A Prospective Head-to-Head Comparison With [18F]FDG
Abstract
BACKGROUND:
Infective endocarditis (IE) can be challenging to diagnose. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]-fluoro-d-glucose ([18F]FDG) is recommended as a diagnostic tool in the guidelines, but holds limitations. The aim of this study was to compare the tracer uptake between the novel [64Cu]Cu-DOTATATE, which has low cardiac uptake and does not require fasting or dietary restrictions, and [18F]FDG in patients with IE and examine the sensitivity and specificity.
METHODS:
The CuDOS study (Cu-Dotatate Positron Emissions Tomography in Infective Endocarditis) was a prospective study including 20 patients with IE (10 with prosthetic valve endocarditis and 10 with native valve endocarditis) and 20 controls. All participants underwent [64Cu]Cu-DOTATATE and [18F]FDG PET/CT. Scans were read blinded to clinical data. Tracer uptakes were measured as maximum standardized uptake values in each heart valve. Differences were tested with Wilcoxon rank tests.
RESULTS:
The median age of the cases and controls was 68 years (interquartile range [IQR], 55.0–75.5) and 61 years (IQR, 57.0–69.5), respectively. [64Cu]Cu-DOTATATE uptake (median maximum standardized uptake value [IQR]) in patients with IE was higher than in controls (2.34 [1.40–3.23] versus 1.44 [1.21–1.60]; P =0.008), although this difference was mainly driven by prosthetic valve endocarditis cases (3.23 [2.02–3.86]; P <0.001) and not between native valve endocarditis cases and controls (1.51 [1.23–2.58]; P=0.428). The sensitivity of [64Cu]Cu-DOTATATE and [18F]FDG PET/CT in 20 cases versus 20 controls were equal, and the specificity was 90% and 75%, respectively. The analysis of prosthetic valve endocarditis versus the 20 controls showed equal sensitivity (80%), and a specificity of 90% and 75%, respectively (P =0.38). In addition, a greater proportion of scans achieved diagnostic certainty with [64Cu]Cu-DOTATATE PET/CT compared with [18F]FDG PET/CT for native valve endocarditis, prosthetic valve endocarditis, and controls.
CONCLUSIONS:
[64Cu]Cu-DOTATATE PET/CT showed uptake in the infected valve in patients with IE, and has major advantage as it does not require any preparation compared with [18F]FDG. [64Cu]Cu-DOTATATE had a numerically higher specificity than [18F]FDG, although the difference was not statistically significant. Both tracers were limited in the detection of native valve endocarditis.
REGISTRATION:
URL: https://www.clinicaltrials.gov; Unique identifier: NCT05432427. www.clinicaltrialsregister.eu; Unique identifier: 2021-005501-27.
Graphical Abstract

Get full access to this article
View all available purchase options and get full access to this article.
Supplemental Material
Figures S1–S6
Tables S1–S2
- Download
- 2.67 MB
References
1.
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;:882–893. doi: 10.1016/S0140-6736(15)00067-7
2.
Wang A, Athan E, Pappas PA, Fowler VGJ, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, et al; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;:1354–1361. doi: 10.1001/jama.297.12.1354
3.
Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. 2017;:1652–1660. doi: 10.1001/jama.2017.4287
4.
Bayer AS, Chambers HF. Prosthetic valve endocarditis diagnosis and management—new paradigm shift narratives. Clin Infect Dis. 2021;:1687–1692. doi: 10.1093/cid/ciab036
5.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, et al; ESC Scientific Document Group. 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;:3075–3128. doi: 10.1093/eurheartj/ehv319
6.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VGJ, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;:633–638. doi: 10.1086/313753
7.
Philip M, Tessonier L, Mancini J, Mainardi JL, Fernandez-Gerlinger MP, Lussato D, Attias D, Cammilleri S, Weinmann P, Hagege A, et al. Comparison between ESC and Duke criteria for the diagnosis of prosthetic valve infective endocarditis. JACC Cardiovasc Imaging. 2020;:2605–2615. doi: 10.1016/j.jcmg.2020.04.011
8.
Pijl JP, Nienhuis PH, Kwee TC, Glaudemans AWJM, Slart RHJA, Gormsen LC. Limitations and pitfalls of FDG-PET/CT in infection and inflammation. Semin Nucl Med. 2021;:633–645. doi: 10.1053/j.semnuclmed.2021.06.008
9.
Gomes A, Glaudemans AWJM, Touw DJ, van Melle JP, Willems TP, Maass AH, Natour E, Prakken NHJ, Borra RJH, van Geel PP, et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis. 2017;:e1–e14. doi: 10.1016/S1473-3099(16)30141-4
10.
Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, et al; European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;:328–354. doi: 10.1007/s00259-014-2961-x
11.
Balink H, Hut E, Pol T, Flokstra FJ, Roef M. Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet. J Nucl Med Technol. 2011;:185–189. doi: 10.2967/jnmt.110.076489
12.
Laznicek M, Laznickova A, Maecke HR. Receptor affinity and preclinical biodistribution of radiolabeled somatostatin analogs. Anticancer Res. 2012;:761–766.
13.
Reubi JC, Schär JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Mäcke HR. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;:273–282. doi: 10.1007/s002590050034
14.
Johnbeck CB, Knigge U, Kjær A. PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncol. 2014;:2259–2277. doi: 10.2217/fon.14.139
15.
Lepidi H, Casalta JP, Fournier PE, Habib G, Collart F, Raoult D. Quantitative histological examination of bioprosthetic heart valves. Clin Infect Dis. 2006;:590–596. doi: 10.1086/500135
16.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;:377–381. doi: 10.1016/j.jbi.2008.08.010
17.
Zauner F, Glück T, Salzberger B, Ehrenstein B, Beutel G, Robl F, Hanses F, Birnbaum D, Linde HJ, Audebert F. Are histopathological findings of diagnostic value in native valve endocarditis? Infection. 2013;:637–643. doi: 10.1007/s15010-013-0404-4
18.
Morris AJ, Drinkovic D, Pottumarthy S, Strickett MG, MacCulloch D, Lambie N, Kerr AR. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis. 2003;:697–704. doi: 10.1086/367842
19.
Toner YC, Ghotbi AA, Naidu S, Sakurai K, van Leent MMT, Jordan S, Ordikhani F, Amadori L, Sofias AM, Fisher EL, et al. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation. Sci Rep. 2022;:6185. doi: 10.1038/s41598-022-09590-2
20.
Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VGJ, Gordon D, Grossi P, Hannan M, et al; International Collaboration on Endocarditis–Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;:1495–1504. doi: 10.1001/jamainternmed.2013.8203
21.
Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;:407–416. doi: 10.1056/NEJM199608083350607
22.
Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV, Starks LT, Martin-Garrido A, Manavaki R, Yu E, et al. Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [18F]FDG PET imaging. J Am Coll Cardiol. 2017;:1774–1791. doi: 10.1016/j.jacc.2017.01.060
23.
Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, Oristrell G, Gracia-Sánchez L, González JJ, Rodríguez-Palomares J, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation. 2015;:1113–1126. doi: 10.1161/CIRCULATIONAHA.115.015316
24.
Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, Casalta JP, Gouriet F, Riberi A, Avierinos JF, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;:2374–2382. doi: 10.1016/j.jacc.2013.01.092
25.
Philip M, Delcourt S, Mancini J, Tessonnier L, Cammilleri S, Arregle F, Martel H, Oliver L, Hubert S, Renard S, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of native valve infective endocarditis: a prospective study. Arch Cardiovasc Dis. 2021;:211–220. doi: 10.1016/j.acvd.2020.10.005
26.
Hess S, Blomberg BA, Zhu HJ, Høilund-Carlsen PF, Alavi A. The pivotal role of FDG-PET/CT in modern medicine. Acad Radiol. 2014;:232–249. doi: 10.1016/j.acra.2013.11.002
27.
Pfeifer A, Knigge U, Mortensen J, Oturai P, Berthelsen AK, Loft A, Binderup T, Rasmussen P, Elema D, Klausen TL, et al. Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study. J Nucl Med. 2012;:1207–1215. doi: 10.2967/jnumed.111.101469
28.
Malmberg C, Ripa RS, Johnbeck CB, Knigge U, Langer SW, Mortensen J, Oturai P, Loft A, Hag AM, Kjær A. 64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: head-to-head comparison with 68Ga-DOTATOC in 60 patients. J Nucl Med. 2015;:1895–1900. doi: 10.2967/jnumed.115.161216
29.
Leupe H, Ahenkorah S, Dekervel J, Unterrainer M, Van Cutsem E, Verslype C, Cleeren F, Deroose CM. 18F-labeled somatostatin analogs as PET tracers for the somatostatin receptor: ready for clinical use. J Nucl Med Off Publ Soc Nucl Med. 2023;:835–841. doi: 10.2967/jnumed.123.265622
Information & Authors
Information
Published In
Copyright
© 2025 American Heart Association, Inc.
History
Received: 31 May 2024
Accepted: 15 November 2024
Published online: 4 February 2025
Keywords
Subjects
Authors
Disclosures
Dr Bull Rasmussen is a full-time employee of Novo Nordisk. Dr Bundgaard receives lecture fees from Amgen, BMS, MSD, Pfizer, and Sanofi. Dr Bruun has received investigator-initiated grants from The Novo Nordisk Foundation, The Augustinus Foundation, The Kaj Hansen Foundation, and Health Insurance Denmark, not related to this study. Dr Tuxen reports speaker fees from Orion Pharma and Novartis and personal fees for advisory board participation from Boehringer Ingelheim and Bayer A/s, all outside the submitted work. Dr Køber has received lecture fees from Astra Zeneca, Bayer, Boehringer, Novartis, and Novo, unrelated to this manuscript. Dr Kjær is an Inventor/IPR holder on patent covering 64Cu-DOTATATE and receives a grant from PERSIMUNE through the Danish National Research Foundation (grant 126).
Dr Fosbøl receives Novo Nordisk Foundation and the Danish Heart Association Independent research grants related to valvular heart disease and endocarditis. The other authors report no conflicts.
Sources of Funding
Supported by the Department of Cardiology and Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital—Rigshospitalet, Copenhagen, Denmark.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.